Drug Interactions between Opioids and Antiretroviral Medications: Interaction between Methadone, LAAM, and Delavirdine

REFERENCES

• McCance-Katz EF, Cropsey K, Gourevitch M. Responding to Intravenous Drug Use (IDU) among People Living with HIV/AIDS: An International Review. Geneva, Switzerland: World Health Organization; in press.
   Google Scholar
• McCance-Katz EF, Kosten TR. Psychopharmacological treatments. In: Miller S, Frances R, eds. Clinical Textbook of Addictive Disorders. 3rd ed. New York, NY: Guilford Press; 2005:588–614.
   Google Scholar
• Yeni PG, Hammer SM, Carpenter CC, et al. Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society—USA Panel. JAMA. 2002;288:222–235. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Dybul M, Fauci AS, Bartlett JG, Kaplan JE, Pau AK. Panel on clinical practices for treatment of HIV: guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Ann Intern Med. 2002;137:381–433. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Gourevitch MN, Friedland GH. Interactions between methadone and medications used to treat HIV infection: a review. Mt Sinai J Med. 2000;67:429–436. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Clarke SM, Mulcahy FM, Tjia J, , et al. The pharmacokinetics of methadone in HIV-positive patients receiving the non-nucleoside reverse transcriptase inhibitor efavirenz. Br J Clin Pharmacol. 2001;51:213–217. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Altice FL, Friedland GH, Cooney EL. Nevirapine induced opioid withdrawal among injection drug users with HIV infection receiving methadone. AIDS. 1999;13:957–962. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• McCance-Katz EF, Rainey P, Friedland G, Jatlow P. The protease inhibitor lopinavir/ritonavir may produce opioid withdrawal in methadone-maintained patients. Clini Infect Dis. 2003;37:476–482. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Akerele EO, Levin F, Nunes E, Brady, Kleber H. Effects of HIV triple therapy on methadone levels. Am J Addict. 2002;11:308–314. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• McCance-Katz EF, Rainey PM, Friedland G, Kosten TR, Jatlow P. Effect of opioid dependence pharmacotherapies on zidovudine disposition. Am J Addict. 2002;10:296–307. [CSA]
   Web of Science ®Google Scholar
• McCance-Katz EF, Rainey P, Smith P, , et al. Drug interactions between opioid and antiretroviral medications: interaction between methadone, LAAM, and nelfinavir. Am J Addict. 2004;13:163–180. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Freimuth W. Delavirdine mesylate, a potent non-nucleoside HIV-1 reverse transcriptase inhibitor. Antiviral Chemotherapy. 1996;4:279–289. [CSA]
   Google Scholar
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed., Text revision, Washington, DC: American Psychiatric Association; 2000.
   Google Scholar
• Sheehan DV, Lecrubier Y, Sheehan HK, , et al. The mini-international neuropsychiatric interview (MINI): the development and validation of a structured diagnostic interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59((Suppl 20)):22–23. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Handlesman L, Cochrane KJ, Aronson MJ, , et al. Two new rating scales for opioid withdrawal. Am J Drug Alcohol Abuse. 1987;13:293–308. [CSA]
   PubMed Web of Science ®Google Scholar
• Folstein MF, Folstein SE, McHugh PR. “Mini-Mental State”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–198. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Shelton MJ, Hewitt RG, Adams J, Della-Coletta A, Cox S, Morse GD. Pharmacokinetics of ritonavir and DLV in human immunodeficiency virus-infected patients. Antimicrob Agents Chemother. 2003;47:1694–1699. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• WinNonlin 1.0 TM [computer program]. Apex, NC: Scientific Consulting Inc.; 1995.
   Google Scholar
• Borenstein M, Cohen J. Statistical Power Analysis: A Computer Program; Lawrence Erlbaum Associates Inc., July 1989.
   Google Scholar
• Cohen J. Statistical Power Analysis for the Behavioral Sciences. Hillsdale, NJ: Lawrence Erlbaum Associates, Hove and London; 1988.
   Google Scholar
• McCance-Katz EF, Rainey PM, Jatlow P, Friedland G. Methadone effects on zidovudine disposition (AIDS clinical trials group 262). J Acquir Immune Defic Syndr. 1998;18:435–443. [CSA]
   Web of Science ®Google Scholar
• Voorman RL, Maio SM, Hauer MJ, Sanders PE, Payne NA, Ackland MJ. Metabolism of delavirdine, a human immunodeficiency virus type-1 reverse transcriptase inhibitor, by microsomal cytochrome P450 in humans, rats, and other species: probable involvement of CYP2D6 and CYP3A. Drug Metab Dispos. 1998;26:631–639. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Cheng CL, Smith DE, Carver PL, , et al. Steady-state pharmacokinetics of delavirdine in HIV-positive patients: effect on erythromycin breath test. Clin Pharmacol Ther. 1997;61:531–543. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Iribarne C, Berthou F, Baird S, , et al. Involvement of cytochrome P450 3A4 enzyme in the n-demethylation of methadone in human liver microsomes. Chem Res Toxicol. 1996;9:365–373. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Moody DE, Alburges ME, Parker RJ, Collins JM, Strong JM. The involvement of cytochrome P 450 3A4 in the n-demethylation of l-alpha-acetylmethadol (LAAM), norLAAM, and methadone. Drug Metab Dispos. 1997;25:1347–1353. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Neff JA, Moody DE. Differential n-demethylation of l-α-acetylmethadol (LAAM) and norLAAM by cytochrome P450s 2B6, 2C18, and 3A4. Biochem Biophys Res Commun. 2001; 284:751–756. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• White JM, Irvine RJ. Mechanisms of fatal opioid overdose. Addiction. 1999;94:961–972. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Stickney JL. Cardiac effects of l-alpha-acetylmethadol, part I: chronotropic effects in vitro. Toxicol Appl Pharmacol. 1977;40:23–32. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Stickney JL, Keedy JD. Cardiac effects of l-alpha-acetylmethadol (LAAM) in different species. General Pharmacology. 1979;10:359–362. [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Stickney JL, Eikenburg DC, Keedy JD. General cardiovascular pharmacology of l-alpha-acetyl-methadol (LAAM). NIDA Res Monogr. 1979;27:422–428. [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• European Agency for the Evaluation of Medicinal Products, Human Medicines Evaluation Unit, Product Safety Announcements. EMEA public statement on levoacetylmethadol (Orlaam)—life-threatening ventricular rhythm disorders. 19 December 2000; EMEA/38918/00. Available at: www.emea.eu.int/. Accessed February 27, 2004., [CSA]
   Google Scholar
• Iribarne C, Berthou F, Carlhant D, , et al. Inhibition of methadone and buprenorphine n-dealkylations by three HIV-1 protease inhibitors. Drug Metab Dispos. 1998;26:257–260. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Gerber JG, Rosenkranz S, Segal Y, , et al. Effect of ritonavir/saquinavir on stereoselective pharmacokinetics of methadone: results of AIDS Clinical Trials Group (ACTG) 401. J Acquir Immune Defic Syndr. 2001;27:53–60. [CSA]
   Web of Science ®Google Scholar